Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

The Polypharmacological Effects of Cannabidiol
Jorge Iván Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3271-3271
Open Access | Times Cited: 69
Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 16
Microglia in neuroimmunopharmacology and drug addiction
Hongyuan Li, Linda R. Watkins, Xiaohui Wang
Molecular Psychiatry (2024) Vol. 29, Iss. 6, pp. 1912-1924
Closed Access | Times Cited: 12
Cannabidiol and brain function: current knowledge and future perspectives
Moniek Schouten, Sebastiaan Dalle, Dante Mantini, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 18
Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
Barkha J. Yadav-Samudrala, Benjamin L. Gorman, Karenna M. Barmada, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Psychostimulant and opioid abuse: A perspective from Uruguay
Analía Richeri, R. L. McGregor, Cecilia Scorza
Neuroscience (2025)
Closed Access
Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations
Hee Ra Park, Eun Jin Yang
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1546-1546
Open Access | Times Cited: 32
Cannabidiol Protects against the Reinstatement of Oxycodone-Induced Conditioned Place Preference in Adolescent Male but Not Female Rats: The Role of MOR and CB1R
Justyna Socha, Paweł Grochecki, Marta Marszałek‐Grabska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6651-6651
Open Access | Times Cited: 4
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence
Bertrand Redonnet, Filiz Eren, Guillaume Avenin, et al.
Addiction (2025)
Open Access
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1462-1462
Open Access | Times Cited: 21
The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
Michelle Sexton, José M. Garcia, Aminah Jatoi, et al.
JNCI Monographs (2021) Vol. 2021, Iss. 58, pp. 86-98
Open Access | Times Cited: 25
Multimodal MRI data fusion reveals distinct structural, functional and neurochemical correlates of heavy cannabis use
Dušan Hirjak, Mike M. Schmitgen, Florian Werler, et al.
Addiction Biology (2021) Vol. 27, Iss. 2
Open Access | Times Cited: 24
CBD‐mediated regulation of heroin withdrawal‐induced behavioural and molecular changes in mice
Francisco Navarrete, Ani Gasparyan, Jorge Manzanares
Addiction Biology (2022) Vol. 27, Iss. 2
Open Access | Times Cited: 18
Cannabidiol use and perceptions in France: a national survey
Clémence Casanova, Clémence Ramier, Davide Fortin, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review
Lindsay A. Lo, Caroline A. MacCallum, Kate Nanson, et al.
The Canadian Journal of Psychiatry (2023) Vol. 68, Iss. 8, pp. 557-571
Open Access | Times Cited: 8
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments
Hugo Bayer, Cristina Aparecida Jark Stern, Fernanda Troyner, et al.
Neuropharmacology (2021) Vol. 205, pp. 108913-108913
Closed Access | Times Cited: 18
Neurogenic Interventions for Fear Memory via Modulation of the Hippocampal Function and Neural Circuits
Hee Ra Park, Mudan Cai, Eun Jin Yang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3582-3582
Open Access | Times Cited: 12
Cannabidiol Reduces Nicotine Withdrawal Severity and State Anxiety During an Acute E-cigarette Abstinence Period: A Novel, Open-Label Study
L. Riley Gournay, Jordan Petry, Sarah A. Bilsky, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 4, pp. 996-1005
Closed Access | Times Cited: 6
Evidence from Human Studies for Utilising Cannabinoids for the Treatment of Substance-Use Disorders: A Scoping Review with a Systematic Approach
Kayvan Ali Gharbi, Yvonne Bonomo, Christine Mary Hallinan
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4087-4087
Open Access | Times Cited: 5
Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
Kristine Rømer Thomsen, Birgitte Thylstrup, Emily A. Kenyon, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 169-180
Open Access | Times Cited: 13
Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials
Caroline Vuilleumier, Norbert Scherbaum, Udo Bonnet, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 9
Cannabidiol as a Modulator of the Development of Alcohol Tolerance in Rats
Michał Szulc, Radosław Kujawski, Amanda Pacholak, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1702-1702
Open Access | Times Cited: 5
Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome
James R. Lathrop, Sheldon N. Rosen, Margaret Heitkemper, et al.
Gastroenterology Nursing (2023) Vol. 46, Iss. 3, pp. 208-224
Closed Access | Times Cited: 5
Cannabinoids for Substance Use Disorder Treatment: What Does the Current Evidence Say?
João Ariel Bonar Fernandes, Renato Filev, Thiago Marques Fidalgo
Cannabis and Cannabinoid Research (2023) Vol. 8, Iss. 5, pp. 703-715
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top